Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GBS Vaccine in Pregnant Women
NCT01446289Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2011
- Primary completion
- Apr 2013
- Modality
- Split/Subunit Vaccines
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in group B streptococcal infection comparing Group B Streptococcus Trivalent Vaccine with Placebo (2 arms). Primary endpoints: Geometric Mean Concentrations of Antibodies in Mothers and Infants at Delivery/Birth and Geometric Mean of the Ratios Between Infant Antibody Level and Maternal Antibody Level at Time of Delivery. Started Sep 2011; status: completed.
02
Drugs
group b streptococcus trivalent vaccine
03
Conditions
group B streptococcal infection
Beyond the preview
Go deeper on NCT01446289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01446289.